Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1995-10-19
|
pubmed:abstractText |
The effects of carvedilol (10 mg kg-1 day-1), a peripheral vasodilator and oxygen free radical scavenger, on nerve conduction and blood flow were examined in streptozotocin-diabetic rats. Rats were treated from induction of diabetes for 1 month in a preventive experiment; effects of treatment in non-diabetic rats were also examined. Diabetes caused a 20.0% (P < 0.001) reduction in sciatic motor conduction and a 14.7% (P < 0.001) deficit in saphenous sensory conduction. Diabetic rats given carvedilol treatment had motor and sensory conduction velocities which did not differ significantly from those of non-diabetic controls, but were greater than for untreated diabetes (P < 0.001). Carvedilol treatment did not significantly alter nerve conduction in non-diabetic rats. The nutritive (capillary) component of sciatic endoneurial blood flow, measured by microelectrode polarography and hydrogen clearance, was 45.8% (P < 0.001) reduced by diabetes. This was completely corrected (P < 0.001) by carvedilol treatment in diabetic rats, flow being in the upper half of the non-diabetic range. In non-diabetic rats, carvedilol caused a 30.6% (P < 0.05) elevation in blood flow. Hydrogen clearance data also revealed a shift away from non-nutritive (arterio-venous anastomotic) towards nutritive flow in treated diabetic rats (P < 0.05). We conclude that the data support a neurovascular hypothesis of diabetic neuropathy. Carvedilol, via vasodilator and anti-oxidant actions, prevents the nutritive blood flow changes that lead to nerve dysfunction.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Carbazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Propanolamines,
http://linkedlifedata.com/resource/pubmed/chemical/Streptozocin,
http://linkedlifedata.com/resource/pubmed/chemical/Vasodilator Agents,
http://linkedlifedata.com/resource/pubmed/chemical/carvedilol
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0028-1298
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
351
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
630-5
|
pubmed:dateRevised |
2010-8-25
|
pubmed:meshHeading |
pubmed-meshheading:7675122-Animals,
pubmed-meshheading:7675122-Carbazoles,
pubmed-meshheading:7675122-Diabetes Mellitus, Experimental,
pubmed-meshheading:7675122-Male,
pubmed-meshheading:7675122-Neural Conduction,
pubmed-meshheading:7675122-Peripheral Nerves,
pubmed-meshheading:7675122-Propanolamines,
pubmed-meshheading:7675122-Rats,
pubmed-meshheading:7675122-Regional Blood Flow,
pubmed-meshheading:7675122-Streptozocin,
pubmed-meshheading:7675122-Vasodilator Agents
|
pubmed:year |
1995
|
pubmed:articleTitle |
Neuroprotective effects of carvedilol in diabetic rats: prevention of defective peripheral nerve perfusion and conduction velocity.
|
pubmed:affiliation |
Department of Biomedical Sciences, University of Aberdeen, Marischal College, Scotland, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|